Disclosure Of Entity's Operating Segments [Text Block]

ERYTECH Pharma S.A. - Filing #880081

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
EUR
EUR
EUR
Tax expense (income)
2,000 EUR
3,000 EUR
1,000 EUR
Profit (loss)
53 797 EUR
53 797 EUR
73 300 EUR
73 300 EUR
62 659 EUR
62 659 EUR
Assets
66 768 EUR
80 402 EUR
118 545 EUR
Cash flows from (used in) operating activities
56 770 EUR
51 720 EUR
43 310 EUR
Cash flows from (used in) investing activities
345,000 EUR
1 475 EUR
19 838 EUR
Cash flows from (used in) financing activities
44 712 EUR
25 449 EUR
40,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.